Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Cancer Science|February 23, 2011
Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancerHideya Onishi, Masaya Kai, Seiichi Odate, et al.
Cancer Immunology, Immunotherapy : CII|February 8, 2005
Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loopHideya Onishi, Hideo Kuroki, Kotaro Matsumoto, et al.
Lung Cancer (Amsterdam, Netherlands)|January 15, 2013
TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinomaSeiichi Odate, Katsuya Nakamura, Hideya Onishi, et al.
Anticancer Research|July 5, 2018
Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell LinesMakoto Kubo, Masayo Umebayashi, Kanako Kurata, et al.
Immunological Investigations|July 15, 2020
Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant AscitesTakashi Morisaki, Tetsuro Hikichi, Hideya Onishi, et al.
International Journal of Cancer|March 5, 2016
Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor modelsKentaro Shinkai, Kenji Nakano, Lin Cui, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 13, 2017
Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinomaKeigo Ozono, Yoshihiro Ohishi, Hideya Onishi, et al.
Scientific Reports|January 11, 2023
Effects of periodontal pathogen-induced intestinal dysbiosis on transplant immunity in an allogenic skin graft modelTakanori Mei, Hiroshi Noguchi, Ryutaro Kuraji, et al.
Anticancer Research|May 2, 2018
Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like CholangiocarcinomaMakoto Kawamoto, Masayo Umebayashi, Hiroto Tanaka, et al.
Oncology Reports|March 22, 2022
Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review)Hideya Onishi, Katsuya Nakamura, Kosuke Yanai, et al.
Pageof 12